Pharmx Technologies Limited · ASX:PHX
Pharmx Technologies — Shareholder Meeting (November 2024)
9 slides from Pharmx Technologies's shareholder meeting presentation, Nov 26, 2024
Slide 1: Chairman's Address
PharmX Technologies Limited ABN 25 000 091 305 Level 11, 17 Castlereagh Street, Sydney NSW 2000 www.pharmx.com.au Annual General Meeting 26 November 2024 Chairman’s Address 2024 marked a pivotal year for the Company. We finalised our strategic transformation, with the disposal of the legacy pharmacy
Slide 2: Chairman's Address (continued)
organisations, positioning PharmX as a leader in healthcare analytics. Focusing on product and technology, we have developed our own data platform, enhanced our core technology platform and continued to expand our Marketplace services, actions that are paying dividends while we set the framework for
Slide 3: About PharmX Technologies Ltd.
outstanding efforts to date, and a sincere thank you to our shareholders for your ongoing support. - ENDS - This announcement is authorised for release by the Board of PharmX Technologies Limited. For further information contact: Tom Culver For personal use only Chief Executive Officer investor.rela
Slide 4: FY24 Annual General Meeting
PharmX AGM For personal use only PRESENTATION PHARMX TECHNOLOGIES LTD (ASX:PHX) FY24 Annual General Meeting Chairman, Nick England 26 November 2024
Slide 5: Notice & Disclaimer
NOTICE & DISCLAIMER This presentation has been prepared by PharmX Technologies Limited (PharmX or the Although the Company believes that the expectations reflected in the forward-looking For personal use only Company or PHX). It should not be considered as an offer or invitation to subscribe for, st
Slide 6: Expert board
EXPERT For personal use only Nick England Jon Newbery Jayne Shaw Dennis Bastas Sandy Mellis PharmX has a robust Chairman Director & Interim CFO Non-Executive Director Non-Executive Director Non-Executive Director governance structure, 35 years of senior +30 years experience Executive roles in two Ma
Slide 7: Strategic milestones
STRATEGIC Divestment of software business Capital distribution For personal use only to shareholders MILESTONES Sold legacy software to Jonas Software which completed Sept 23. $1.26M deferred consideration received Sept 24. ~$4.49M distributed to shareholders in Dec 23 amounting $0.75cps. GROWTH Str
Slide 8: Key strategic pillars
KEY STRATEGIC For personal use only Dedicated Strong financial Strategic Strong commercial Advanced analytics growth strategy performance partnerships growth and data Launch of refocused growth Immediate strategic changes Renewal of key contracts, Gateway delivers strong Customer centered product st
Slide 9: Thank You
PharmX For personal use only THANK YOU investor.relations@pharmx.com.au Suite 11.02, Level 11,17 Castlereagh Street, Sydney 2000
PharmX Technologies — Shareholder Meeting (November 2024) on 6ix